David Hirsch

David Hirsch is the CEO of Alpha-9 Theranostics Inc. David has extensive experience in the healthcare industry, serving as a venture partner, founder, and managing director at Longitude Capital. David also holds board positions at several companies including Rapid Micro Biosystems, Tricida, Inc., Molecular Templates, and others. With an MD from Harvard Medical School, a PhD in Biology from Massachusetts Institute of Technology, and a BA in Biology from The Johns Hopkins University, David brings a strong educational background to their leadership roles in the biotechnology sector.